Skip to content

VERDE BIO HOLDINGS, INC.: 10-Q/A filed 2020-09-28

What VERDE BIO HOLDINGS, INC. reported in its quarterly report amendment filed 2020-09-28 (fiscal Q1 2021): 13 published measures, 28 facts as tagged in accession 0001445866-20-001408.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form
10-Q/A (quarterly report amendment)
Filed
2020-09-28
Fiscal period
fiscal Q1 2021
Accession
0001445866-20-001408 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All VERDE BIO HOLDINGS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-07-312,779USD
At 2020-04-301,631USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-07-313,602,417USD
At 2020-04-303,136,509USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-07-31-3,599,638USD
At 2020-04-30-3,134,878USD
At 2019-07-31-2,236,756USD
At 2019-04-30-2,006,707USD

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2020-05-01 to 2020-07-31-61,769USD92
2019-05-01 to 2019-07-31-9,296USD92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2020-05-01 to 2020-07-3162,917USD92
2019-05-01 to 2019-07-310USD92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-07-31-8,432,292USD
At 2020-04-30-7,521,745USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2020-05-01 to 2020-07-31-341,562USD92
2019-05-01 to 2019-07-31-43,757USD92

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2020-05-01 to 2020-07-3196,717USD92
2019-05-01 to 2019-07-3125,363USD92

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2020-05-01 to 2020-07-31341,562USD92
2019-05-01 to 2019-07-3143,757USD92

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-07-3130,009,078shares
At 2020-04-301,829,867shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2020-07-314,787,145USD
At 2020-04-304,384,537USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2020-05-01 to 2020-07-31-910,547USD92
2019-05-01 to 2019-07-31-386,428USD92

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2020-05-01 to 2020-07-31-568,985USD92
2019-05-01 to 2019-07-31-342,671USD92

Inspect the source

Entity
VERDE BIO HOLDINGS, INC. / CIK 0001490054
Captured
2026-09-19T11:18:19.126Z
SEC response SHA-256
dd7cd08239c5c2462afbc7dbecad94ca6a89142a02ded38321628f853eea98c8

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001490054.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))